| scholarly article | Q13442814 |
| P50 | author | Bence Sipos | Q40927701 |
| Günter Klöppel | Q40929844 | ||
| Susanne Müerköster | Q40930761 | ||
| P2093 | author name string | Holger Kalthoff | |
| Ulrich R Fölsch | |||
| Alexander Arlt | |||
| Heiner Schäfer | |||
| Maike Grossmann | |||
| Maike Witt | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic carcinoma | Q18556536 |
| P304 | page(s) | 1316-24 | |
| P577 | publication date | 2005-02-15 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells | |
| P478 | volume | 65 |
| Q91756627 | A Propensity Score-adjusted Analysis of the Effects of Ubiquitin E3 Ligase Copy Number Variation in Peripheral Blood Leukocytes on Colorectal Cancer Risk |
| Q28943270 | A genome-wide association study of overall survival in pancreatic cancer patients treated with gemcitabine in CALGB 80303 |
| Q41712580 | A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle |
| Q38084210 | A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer |
| Q37590127 | Ablation of gly96/immediate early gene-X1 (gly96/iex-1) aggravates DSS-induced colitis in mice: role for gly96/iex-1 in the regulation of NF-kappaB. |
| Q40317242 | Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1beta and NO lead to inactivation of caspases |
| Q52572385 | Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation. |
| Q36907152 | Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals |
| Q34127839 | Circadian gene variants in cancer. |
| Q24294824 | Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells |
| Q46476904 | Colonic Lamina Propria Inflammatory Cells from Patients with IBD Induce the Nuclear Factor-E2 Related Factor-2 Thereby Leading to Greater Proteasome Activity and Apoptosis Protection in Human Colonocytes |
| Q92350926 | Controlling Nuclear NF-κB Dynamics by β-TrCP-Insights from a Computational Model |
| Q37096504 | Copy number variation of E3 ubiquitin ligase genes in peripheral blood leukocyte and colorectal cancer |
| Q38924935 | DEPTOR has growth suppression activity against pancreatic cancer cells |
| Q53690290 | DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer. |
| Q24648025 | Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer |
| Q30278581 | Deregulation of F-box proteins and its consequence on cancer development, progression and metastasis |
| Q28086796 | Dysregulation of ubiquitin ligases in cancer |
| Q35082710 | E3 ubiquitin ligases as cancer targets and biomarkers |
| Q47636038 | E3 ubiquitin ligases in cancer and implications for therapies |
| Q39319533 | EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-κB activation |
| Q55253244 | F-box proteins involved in cancer-associated drug resistance. |
| Q36184419 | Genomics of pancreatic cancer: does it make any improvement in diagnosis, prognosis and therapy? |
| Q39242497 | Inflammatory macrophages induce Nrf2 transcription factor-dependent proteasome activity in colonic NCM460 cells and thereby confer anti-apoptotic protection |
| Q33714709 | Inhibition of Neddylation Modification Sensitizes Pancreatic Cancer Cells to Gemcitabine |
| Q38835111 | Inhibition of Survival Pathways MAPK and NF-kB Triggers Apoptosis in Pancreatic Ductal Adenocarcinoma Cells via Suppression of Autophagy. |
| Q39251887 | Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity |
| Q39693828 | L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression |
| Q38577492 | MicroRNA regulation of F-box proteins and its role in cancer. |
| Q38734954 | MicroRNA-182 promotes pancreatic cancer cell proliferation and migration by targeting β-TrCP2. |
| Q39047635 | Modulation of nuclear factor E2-related factor-2 (Nrf2) activation by the stress response gene immediate early response-3 (IER3) in colonic epithelial cells: a novel mechanism of cellular adaption to inflammatory stress |
| Q37293337 | NF-kappaB signaling pathway and its therapeutic implications in human diseases |
| Q28384956 | NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis |
| Q36637905 | Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression |
| Q44037295 | Overexpression of RING box protein-1 (RBX1) associated with poor prognosis of non-muscle-invasive bladder transitional cell carcinoma |
| Q39235953 | Prolonged exposure to acid and bile induces chromosome abnormalities that precede malignant transformation of benign Barrett's epithelium |
| Q36337922 | Prospects of RNA interference therapy for cancer |
| Q28390295 | REDD1, an inhibitor of mTOR signalling, is regulated by the CUL4A-DDB1 ubiquitin ligase |
| Q38052131 | Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases |
| Q38828721 | Recent advances in SCF ubiquitin ligase complex: Clinical implications |
| Q48375223 | Reciprocal regulation between βTrCP and Smurf1 suppresses proliferative capacity of liver cancer cells. |
| Q38881445 | Regulation of cancer stem cells by RING finger ubiquitin ligases |
| Q36877896 | Relevance of Sp Binding Site Polymorphism in WWOX for Treatment Outcome in Pancreatic Cancer. |
| Q35012352 | Roles of F-box proteins in cancer |
| Q21090517 | Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism |
| Q35613215 | SAG/ROC-SCF beta-TrCP E3 ubiquitin ligase promotes pro-caspase-3 degradation as a mechanism of apoptosis protection |
| Q36119281 | SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB. |
| Q35880315 | SCF E3 ubiquitin ligases as anticancer targets |
| Q37589134 | SCF β-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration |
| Q37724387 | Targeting NF-kappaB for colorectal cancer |
| Q26866185 | Targeting the ubiquitin pathway for cancer treatment |
| Q35726483 | The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells |
| Q36029051 | The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis |
| Q38087182 | The ubiquitin proteasome system - implications for cell cycle control and the targeted treatment of cancer |
| Q37591349 | The β-TrCP-FBXW2-SKP2 axis regulates lung cancer cell growth with FBXW2 acting as a tumour suppressor |
| Q29617992 | Ubiquitin ligases: cell-cycle control and cancer |
| Q89611790 | lncRNA SLC7A11-AS1 Promotes Chemoresistance by Blocking SCFβ-TRCP-Mediated Degradation of NRF2 in Pancreatic Cancer |
| Q98384399 | β-TrCP suppresses the migration and invasion of trophoblast cells in preeclampsia by down-regulating Snail |
Search more.